These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 17174510

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY, Ng SY, Teo L, Koh Y, Teok CH.
    J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
    [Abstract] [Full Text] [Related]

  • 8. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH.
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 Nov; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 12. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M, Piekarska K, Gierczyński R.
    Med Dosw Mikrobiol; 2012 Nov; 64(4):285-95. PubMed ID: 23484420
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of the MicroScan NegCombo panel Type 44 for detection of extended-spectrum beta-lactamase among clinical isolates of Escherichia coli, Klebsiella species, and Proteus mirabilis].
    Ko SY, Chung JW, Song AJ, Yoon NS, Sung H, Kim MN.
    Korean J Lab Med; 2009 Feb; 29(1):35-40. PubMed ID: 19262076
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases.
    Aragón LM, Mirelis B, Miró E, Mata C, Gómez L, Rivera A, Coll P, Navarro F.
    J Antimicrob Chemother; 2008 May; 61(5):1029-32. PubMed ID: 18292096
    [Abstract] [Full Text] [Related]

  • 18. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M, Fatima N, Rashid M, Shukla I, Malik A, Usman A, Siddiqui S.
    J Infect Dev Ctries; 2009 May 01; 3(4):285-94. PubMed ID: 19759492
    [Abstract] [Full Text] [Related]

  • 19. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M, Fatima N, Rashid M, Shukla I, Malik A, Usman A, Siddiqui S.
    J Infect Dev Ctries; 2009 Apr 30; 3(3):177-86. PubMed ID: 19759472
    [Abstract] [Full Text] [Related]

  • 20. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H, Midilli K, Oğünç D, Ozen N, Ongüt G, Dağlar D, Mutlu D, Ozhak B, Colak D.
    Mikrobiyol Bul; 2008 Oct 30; 42(4):545-51. PubMed ID: 19149075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.